BSEResult12 Aug 2026 · 12 Aug 2026, 08:01 pm
Unaudited Financial Results for the first quarter ended 30 June 2026.
Arvaya Healthcare Ltd · 524723
✦ AI SummaryResults
Arvaya Healthcare Ltd has announced unaudited financial results for the first quarter ended 30 June 2026, with the Board of Directors approving material related party transactions and appointments of Company Secretary and Independent Directors.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern3/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Arvaya Healthcare Ltd - 524723 - Unaudited Financial Results For The First Quarter Ended 30 June 2026.
Attachments (1)
📄pdf
Download →
aa4d68b9-65cc-4bb4-925e-cf297237c3eb.pdf
View document text
August 12, 2026
The Secretary,
Listing Department
Bombay Stock Exchange Ltd
Phiroze Jeejeebhoy Towers,
Street, Mumbai – 400 001
Reference: Scrip Code: 524723/ ISIN: INE491D01017
Subject: Outcome of Meeting of Board of Directors of Arvaya Healthcare Limited (Formerly Known as
Bijoy Hans Limited) (“the Company”) in accordance with Regulation 30 of the SEBI (Listing Obligation
and Disclosure Requirements) Regulation, 2015 (“Listing Regulation”)
Respected Authorities,
Pursuant to the Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure
Requirements) Regulations, 2015, we wish to inform that the meeting of the Board of Directors of the Arvaya
Healthcare Limited (Formerly Known as Bijoy Hans Limited) (“Company”) held today i.e. Wednesday, August
12, 2026 through video conferencing/other audio-visual has inter alia, considered and approved the following
amongst other items of agenda:
1. Approved Material Related Party Transaction(s) of the Company.
The Board of Directors approved the material related party transaction(s) of the Company for the financial year
2026-27, together with the recommendation of the Audit Committee thereon, in terms of Section 188 of the
Companies Act, 2013 and Regulation 23 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015 ("Listing Regulations") subject to the approval of shareholders in ensuing Annual General
Meeting.
It was noted that, in terms of Regulation 23(1) of the Listing Regulations, a transaction with a related party is
considered "material" if the transaction(s) to be entered into individually or taken together with previous
transactions during a financial year exceeds ₹1,000 crore or 10% of the annual consolidated turnover of the
Company as per the last audited financial statements, whichever is lower.
Sr. Name of the Relationship Nature of Transaction Financial
No. Related Party Transaction Amount in Rs Year
1. Agri One India Ventures Promoter of the As per Section 188 and 40 crores 2026-2027
LLP Company. RPT policy of the
Company
2. UG Patwardhan Services Promoter of the As per Section 188 and 40 crores 2026-2027
Private Limited Company RPT policy of the
Company
3. Kaushal Uttam Shah Promoter of the As per Section 188 and 40 crores 2026-2027
Company RPT policy of the
Company
4. GTT Data Solutions The company As per Section 188 and 40 crores 2026-2027
Limited belongs to same RPT policy of the
Promoter Group Company
5. SMCV Management The company As per Section 188 and 50 crores 2026-2027
Services Private Limited belongs to same RPT policy of the
Promoter Group Company
6. Tec pool Solutions Private Wholly owned As placed before the 40 crores 2026-2027
Limited subsidiary Board
7 Health secure Hospitals Wholly owned As placed before the 40 crores 2026-2027
Private Limited subsidiary Board
8 Arvaya Healthtech & Wholly owned As placed before the 40 crores 2026-2027
Wellness Private Limited subsidiary Board
9 Sushodha Institute of Related Party As placed before the 40 crores 2026-2027
Gastroenterology Private Board
Limited
2. Approved the appointment of CS Guinea Agrawal as Company Secretary of Arvaya Healthtech &
Wellness Private Limited, a Wholly owned subsidiary of the Company.
It was informed that Arvaya Healthtech & Wellness Private Limited ("AHWPL"), a Wholly owned subsidiary of
the Company, proposes to appoint CS Guinea Agrawal Company Secretary and Key Managerial Personnel of its
Wholly Subsidiary i.e. Arvaya Healthtech & Wellness Private Limited.
Further, it was informed that in terms of the proviso to Section 203(3) of the Companies Act, 2013, a whole-
time Key Managerial Personnel is restricted from holding office in more than one company at the same time,
except that such person may hold office as a Key Managerial Personnel in one or more of its subsidiary
companies. As AHWPL is a wholly owned subsidiary of the Company, CS Guinea Agrawal is eligible to be
appointed as its Company Secretary while continuing to hold office as Company Secretary of the Company.
The board considered and approved the appointment of CS Guinea Agrawal as Company Secretary of Arvaya
Healthtech & Wellness Private Limited a subsidiary of the Company.
3. Considered and approved the appointment of Mr. Rahul Ravindra Mayur as Additional Director
(Non-Executive Independent Director) on the Boards of Arvaya Healthtech & Wellness Private
Limited, Health Secure Hospitals Private Limited and Tec-Pool Solutions Private Limited, being
subsidiaries of the Company.
It was proposed to appoint Mr. Rahul Ravindra Mayur, Additional Director (Non-Executive Independent
Director) of the Company (DIN:09203474), as an Additional Non-Executive Independent Director on the
Boards of the following subsidiaries of the Company:
(i) Arvaya Healthtech & Wellness Private Limited; (ii) Health Secure Hospitals Private Limited; and (iii) Tec-
Pool Solutions Private Limited (collectively, the "Subsidiary Companies").
Further it was informed that, in terms of Regulation 24(1) of the Listing Regulations, at least one Independent
Director on the Board of Directors of a listed entity is required to be a director on the Board of Directors of an
unlisted "material subsidiary", whether or not such subsidiary is incorporated in India. The board noted the same
and after discussion approved the appointment of Mr. Rahul Ravindra Mayur as an Additional Director (Non-
Executive Independent Director) on the board of the respective 3 subsidiary companies of Arvaya Healthcare
Limited
4. Considered and adopted the Unaudited Standalone and Consolidated Financial Results of the
Company for the quarter ended 30th June, 2026.
Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2026.
The said Unaudited Financial Results prepared in terms of Regulation 33 of the SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) together with the Limited Review
Report are enclosed herewith.
These results are also being uploaded on the Company’s website at https://www.arvayahealth.com/
5. Took note of the Annual Secretarial Compliance Report for the financial year ended 31st March, 2026.
The Annual Secretarial Compliance Report for the financial year ended 31st March 2026 placed before the
Board of Directors issued by the Practicing Company Secretary M/s. SKGK & Associates, LLP in accordance
with Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read
with the applicable SEBI circulars The Board took note of the Annual Secretarial Compliance Report for FY
2025-26.
6. Took of the Secretarial Audit Report of the Company for the financial year ended 31st March, 2026.
The Secretarial Audit Report in Form MR-3 for the financial year ended 31st March, 2026, issued by the
Practicing Company Secretary M/s. SKGK & Associates, LLP pursuant to the provisions of Section 204 of the
Companies Act, 2013 read with Rule 9 of the Companies (Appointment and Remuneration of Managerial
Personnel) Rules, 2014, for inclusion in the Board's Report forming part of the Annual Report of the Company
placed before the Board for its review and consideration. The board reviewed and noted the same.
7. Considered and approved the calling of the Annual General Meeting of the Company.
It was proposed to convene the 41st Annual General Meeting ("AGM") of the Company for the financial year
ended 31st March, 2026, as on Monday, 21st September, 2026 in terms of Section 96 of the Companies Act,
2013.
8. Considered and approved the appointment of Scrutinizer for the e-voting process in relation to the
ensuing Annual General Meeting.
It was informed to the board that, pursuant to Section 108 of the Companies Act, 2013 read with Rule 20 of the
Companies (Management and Administration) Rules, 2014, and Secretarial Standard-2, it was required to appoint
a Scrutinizer for scrutinizing the remote e-voting and e-voting at the meeting process in
[Showing first 8,000 characters — download PDF for full document]